You may be able to join the study if you:

Are at least 18 years old

Were diagnosed with type 2 diabestes for at least 6 months 

Have a hemoglobin A1c of  ≥7% and ≤10%

Have been managing T2D with diet and exercise alone or with either stable dose of metformin and/or SGLT-2 inhibitors (such as Canagliflozin, dapagliflozin or empagliflozin)